Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Transplantation and Cellular Therapy
|
August 6, 2023
Estimating the Cost per Clinical Outcome of Second-Line Liso-Cel Versus Autologous Stem Cell Transplantation in Patients with Transplantation-Intended Relapsed/Refractory Large B Cell Lymphoma
Matia Saeedian, Jack Badaracco, Afraim Botros, et al.
Forum for Health Economics & Policy
|
March 6, 2020
Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis
Sophie Snyder, Christopher S Hollenbeak, Kamyar Kalantar-Zadeh, et al.
JAMA Network Open
|
April 7, 2020
Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
Gary H Lyman, Andy Nguyen, Sophie Snyder, et al.
Critical Care Explorations
|
March 14, 2020
Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis
Carly J Paoli, Mark A Reynolds, Courtney Coles, et al.
Pharmacoeconomics - Open
|
May 4, 2019
A Systematic Review of the Health Economics of Pompe Disease
Benedikt Schoser, Andreas Hahn, Emma James, et al.
Critical Care Medicine
|
July 27, 2018
Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level
Carly J Paoli, Mark A Reynolds, Meenal Sinha, et al.
Preventive Medicine Reports
|
December 19, 2022
Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008-2020
Ashley Kim, Matthew Gitlin, Ela Fadli, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 8, 2018
What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks
Toni Storm-Dickerson, Lopamudra Das, Allen Gabriel, et al.
Journal of Managed Care Pharmacy : JMCP
|
December 4, 2009
Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease
Jeffrey Horowitz, Anil Agarwal, Fannie Huang, et al.
Health Services Research
|
November 19, 2013
Efficiency of U.S. dialysis centers: an updated examination of facility characteristics that influence production of dialysis treatments
Sanatan Shreay, Martin Ma, Jill McCluskey, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Transplantation and Cellular Therapy
|
August 6, 2023
Estimating the Cost per Clinical Outcome of Second-Line Liso-Cel Versus Autologous Stem Cell Transplantation in Patients with Transplantation-Intended Relapsed/Refractory Large B Cell Lymphoma
Matia Saeedian, Jack Badaracco, Afraim Botros, et al.
Forum for Health Economics & Policy
|
March 6, 2020
Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis
Sophie Snyder, Christopher S Hollenbeak, Kamyar Kalantar-Zadeh, et al.
JAMA Network Open
|
April 7, 2020
Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
Gary H Lyman, Andy Nguyen, Sophie Snyder, et al.
Critical Care Explorations
|
March 14, 2020
Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis
Carly J Paoli, Mark A Reynolds, Courtney Coles, et al.
Pharmacoeconomics - Open
|
May 4, 2019
A Systematic Review of the Health Economics of Pompe Disease
Benedikt Schoser, Andreas Hahn, Emma James, et al.
Critical Care Medicine
|
July 27, 2018
Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level
Carly J Paoli, Mark A Reynolds, Meenal Sinha, et al.
Preventive Medicine Reports
|
December 19, 2022
Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008-2020
Ashley Kim, Matthew Gitlin, Ela Fadli, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 8, 2018
What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks
Toni Storm-Dickerson, Lopamudra Das, Allen Gabriel, et al.
Journal of Managed Care Pharmacy : JMCP
|
December 4, 2009
Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease
Jeffrey Horowitz, Anil Agarwal, Fannie Huang, et al.
Health Services Research
|
November 19, 2013
Efficiency of U.S. dialysis centers: an updated examination of facility characteristics that influence production of dialysis treatments
Sanatan Shreay, Martin Ma, Jill McCluskey, et al.
Page
of 6